INFUSION SITE EROSION

INFUSION SITE EROSION was reported 41 times

INFUSION SITE EROSION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Photoenhancer [EPC] 1 0.0003
1 Catechol-O-Methyltransferase Inhibitor [EPC] 1 0.0002
2 Prostacycline Vasodilator [EPC] 24 0.0002
3 Human Immunoglobulin G [EPC] 2 0.0001
4 Prostacyclin Receptor Agonist [EPC] 2 0.0001
5 Central alpha-2 Adrenergic Agonist [EPC] 4 0.0001
6 Phosphodiesterase 5 Inhibitor [EPC] 8 0.0001
7 Soluble Guanylate Cyclase Stimulator [EPC] 2 0.0001
8 Non-Standardized Plant Allergenic Extract [EPC] 1 0.0001
9 Amide Local Anesthetic [EPC] 4 0.0000
10 Bile Acid [EPC] 1 0.0000
11 Antiarrhythmic [EPC] 4 0.0000
12 Endothelin Receptor Antagonist [EPC] 8 0.0000
13 Alkaloid [EPC] 1 0.0000
14 Provitamin D2 Compound [EPC] 1 0.0000
15 Oxazolidinone Antibacterial [EPC] 1 0.0000
16 Tetracycline-class Drug [EPC] 1 0.0000
17 Osmotic Laxative [EPC] 4 0.0000
18 Aldosterone Antagonist [EPC] 2 0.0000
19 Non-Standardized Food Allergenic Extract [EPC] 1 0.0000
20 Nucleoside Analog Antiviral [EPC] 1 0.0000
21 Dietary Cholesterol Absorption Inhibitor [EPC] 1 0.0000
22 Loop Diuretic [EPC] 4 0.0000
23 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
24 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 1 0.0000
25 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
26 Serotonin-3 Receptor Antagonist [EPC] 1 0.0000
27 Factor Xa Inhibitor [EPC] 2 0.0000
28 Microtubule Inhibitor [EPC] 1 0.0000
29 Xanthine Oxidase Inhibitor [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 3 0.0000
31 Benzodiazepine [EPC] 3 0.0000
32 Alkylating Drug [EPC] 1 0.0000
33 Opioid Agonist [EPC] 1 0.0000
34 Platinum-based Drug [EPC] 1 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 4 0.0000
36 Dihydropyridine Calcium Channel Blocker [EPC] 1 0.0000
37 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
38 Atypical Antipsychotic [EPC] 1 0.0000
39 Proton Pump Inhibitor [EPC] 1 0.0000
40 Corticosteroid [EPC] 1 0.0000